Value assessment of NMPA-approved new cancer drugs for solid cancer in China, 2016–2020
BackgroundWhether the high cost of cancer drugs is commensurate with their value to patients, which has become the focus of public concern. We aimed to assess the value of new cancer drugs approved for solid cancer in China and to explore the association between price and value of drugs.MethodsWe id...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2023-02-01
|
| シリーズ: | Frontiers in Public Health |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1109668/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|